SubsidieMeestersOpioid-free Pain relief for Enhanced Recovery After Spine fixation surgery
SentryX is developing Bupi-Ring, a drug delivery system for bupivacaine that provides extended local pain relief post-surgery, aiming to reduce opioid use and improve recovery outcomes.
Projectdetails
Introduction
There is a troubling lack of effective pain treatments after major surgery. Especially after musculoskeletal procedures, patients experience debilitating pain now treated with opioids. Opioids provide insufficient pain relief, have many toxic side effects, and are highly addictive.
Impact of Pain and Opioids
Pain and opioid-related side effects impede early mobilization and recovery and are the primary reasons for extended hospital stays.
Project Overview
SentryX is developing revolutionary drug delivery technology to extend the effects of a well-established local pain blocker called bupivacaine. Its initial use case in spine fixation surgery, Bupi-Ring, delivers bupivacaine directly to the surgical site for more than 72 hours without changing the existing surgical workflow.
Benefits of Bupi-Ring
Non-opioid local pain relief in this critical early phase of recovery will:
- Promote early mobilization
- Shorten hospital stays
- Prevent complications
- Save costs
Conclusion
This project will demonstrate Bupi-Ring’s safety and efficacy in humans for the first time.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 5.687.678 |
Tijdlijn
| Startdatum | 1-4-2023 |
| Einddatum | 31-3-2026 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- SENTRYX BVpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from painNC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments. | EIC Accelerator | € 2.499.999 | 2023 | Details |
SmartFuse: Game-changer to create a new gold-standard for spinal fusion surgery with wirelessly technologyThe project aims to enhance spinal fusion surgery outcomes by integrating a wireless bio-electrical stimulation system into implants to accelerate bone growth and provide real-time healing feedback. | EIC Accelerator | € 2.500.000 | 2022 | Details |
PN6047 - a breakthrough treatment of neuropathic painPharmNovo aims to advance PN6047, a selective delta opioid receptor agonist for neuropathic pain, through Phase IIa trials to confirm efficacy and attract investment for further development. | EIC Accelerator | € 2.493.000 | 2024 | Details |
Inossia Cement Softener - a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patientsThe Inossia Cement Softener reduces bone cement stiffness by 50-75%, improving vertebral augmentation outcomes and significantly lowering fracture risks in osteoporotic patients. | EIC Accelerator | € 2.298.325 | 2023 | Details |
The first true minimally-invasive Spinal Fusion SystemZygoFix's zLOCK implant aims to revolutionize spinal fusion by offering a minimally invasive, outpatient alternative to traditional screw-and-rod methods, with plans for clinical validation and CE-marking. | EIC Accelerator | € 2.220.050 | 2022 | Details |
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from pain
NC Biomatrix's VitaDisc is a revolutionary non-invasive injectable biomatrix that restores disc function and height, addressing disc degeneration and offering a scalable solution for orthopedic treatments.
SmartFuse: Game-changer to create a new gold-standard for spinal fusion surgery with wirelessly technology
The project aims to enhance spinal fusion surgery outcomes by integrating a wireless bio-electrical stimulation system into implants to accelerate bone growth and provide real-time healing feedback.
PN6047 - a breakthrough treatment of neuropathic pain
PharmNovo aims to advance PN6047, a selective delta opioid receptor agonist for neuropathic pain, through Phase IIa trials to confirm efficacy and attract investment for further development.
Inossia Cement Softener - a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patients
The Inossia Cement Softener reduces bone cement stiffness by 50-75%, improving vertebral augmentation outcomes and significantly lowering fracture risks in osteoporotic patients.
The first true minimally-invasive Spinal Fusion System
ZygoFix's zLOCK implant aims to revolutionize spinal fusion by offering a minimally invasive, outpatient alternative to traditional screw-and-rod methods, with plans for clinical validation and CE-marking.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Oral oxytocin for abdominal painThis project aims to develop gut-stable peptide analgesics for effective oral treatment of chronic abdominal pain, addressing a significant unmet medical need and reducing socio-economic burdens. | ERC Proof of... | € 150.000 | 2023 | Details |
Rejuvenation of the Intervertebral Disc Using Self-Healing Biomimetic Extracellular Matrix Biomaterial Tissue AdhesivesThis project aims to develop a self-healing biomimetic hydrogel for treating degenerated intervertebral discs, restoring tissue properties and improving patient outcomes in minimally invasive spine treatments. | ERC Proof of... | € 150.000 | 2024 | Details |
Ontwikkeling van een biocompatibele en bio-afbreekbare zenuwcassetteHet project onderzoekt de technische en economische haalbaarheid van een bio-afbreekbare zenuwcassette om pijnlijke neuromen na amputatie te behandelen en mobiliteitsproblemen te verhelpen. | Mkb-innovati... | € 20.000 | 2022 | Details |
De ontwikkeling van COAST - Customized bOne heAling Spinal implanTDit project ontwikkelt een op maat gemaakte, poreuze spinale kooi om spinale stenose te behandelen, met als doel botgroei te bevorderen en infectierisico's te verminderen. | Mkb-innovati... | € 174.580 | 2021 | Details |
Chronic PAIN eradiCAtion by taRgeting Schwann cEllsPAIN-CARE aims to develop Schwann cell selective analgesic drugs to effectively treat chronic pain with fewer side effects than current NSAIDs and opioids, advancing towards pre-commercialization. | ERC Proof of... | € 150.000 | 2023 | Details |
Oral oxytocin for abdominal pain
This project aims to develop gut-stable peptide analgesics for effective oral treatment of chronic abdominal pain, addressing a significant unmet medical need and reducing socio-economic burdens.
Rejuvenation of the Intervertebral Disc Using Self-Healing Biomimetic Extracellular Matrix Biomaterial Tissue Adhesives
This project aims to develop a self-healing biomimetic hydrogel for treating degenerated intervertebral discs, restoring tissue properties and improving patient outcomes in minimally invasive spine treatments.
Ontwikkeling van een biocompatibele en bio-afbreekbare zenuwcassette
Het project onderzoekt de technische en economische haalbaarheid van een bio-afbreekbare zenuwcassette om pijnlijke neuromen na amputatie te behandelen en mobiliteitsproblemen te verhelpen.
De ontwikkeling van COAST - Customized bOne heAling Spinal implanT
Dit project ontwikkelt een op maat gemaakte, poreuze spinale kooi om spinale stenose te behandelen, met als doel botgroei te bevorderen en infectierisico's te verminderen.
Chronic PAIN eradiCAtion by taRgeting Schwann cElls
PAIN-CARE aims to develop Schwann cell selective analgesic drugs to effectively treat chronic pain with fewer side effects than current NSAIDs and opioids, advancing towards pre-commercialization.